Commodore Capital

Commodore Capital as of Dec. 31, 2023

Portfolio Holdings for Commodore Capital

Commodore Capital holds 32 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Merus N V (MRUS) 11.3 $131M 4.7M 27.50
Xenon Pharmaceuticals (XENE) 8.6 $100M 2.2M 46.06
Nuvalent Inc-a (NUVL) 8.5 $98M 1.3M 73.59
Vera Therapeutics Cl A (VERA) 7.3 $84M 5.5M 15.38
Rhythm Pharmaceuticals (RYTM) 6.2 $71M 1.6M 45.97
Vaxcyte (PCVX) 6.0 $69M 1.1M 62.80
Cabaletta Bio (CABA) 3.7 $43M 1.9M 22.70
Immunovant (IMVT) 3.6 $42M 1.0M 42.13
Miragen Therapeutics (VRDN) 3.6 $42M 1.9M 21.78
Arvinas Ord (ARVN) 3.6 $41M 1.0M 41.16
Spyre Therapeutics Com New (SYRE) 3.5 $41M 1.9M 21.52
Enliven Therapeutics (ELVN) 3.5 $40M 2.9M 13.84
Cogent Biosciences (COGT) 2.8 $33M 5.6M 5.88
Alpine Immune Sciences (ALPN) 2.7 $31M 1.6M 19.06
Soleno Therapeutics (SLNO) 2.4 $28M 700k 40.25
Celldex Therapeutics Com New (CLDX) 2.4 $28M 702k 39.66
Celcuity (CELC) 2.2 $26M 1.8M 14.57
Rayzebio 2.1 $24M 384k 62.17
Pharvaris N V (PHVS) 1.9 $22M 800k 28.05
C4 Therapeutics Com Stk (CCCC) 1.9 $22M 3.8M 5.65
Abivax Sa Sponsored Ads (ABVX) 1.8 $20M 1.9M 10.70
Nkarta (NKTX) 1.6 $18M 2.7M 6.60
Kura Oncology (KURA) 1.6 $18M 1.2M 14.38
Harpoon Therapeutics Com New 1.5 $17M 1.5M 11.37
Akero Therapeutics (AKRO) 1.1 $13M 565k 23.35
Sab Biotherapeutics (SABS) 1.1 $13M 1.8M 6.88
Dyne Therapeutics (DYN) 1.0 $12M 900k 13.30
Vistagen Therapeutics Ord (VTGN) 0.7 $8.1M 1.6M 5.14
Third Harmonic Bio (THRD) 0.7 $7.8M 707k 10.97
Adverum Biotechnologies 0.7 $7.5M 10M 0.75
Apogee Therapeutics (APGE) 0.6 $7.0M 250k 27.94
Dbv Technologies S A Sponsored Adr (DBVT) 0.0 $88k 93k 0.95